Kevin focuses on mergers and acquisitions and other complex corporate transactions, representing public and private companies in their most important strategic matters. His practice also includes advising clients with respect to shareholder activism, corporate governance and takeover defense. He advises clients in a wide range of industries, including technology, life sciences, consumer, entertainment, fintech, financial services, and private equity.

Download full bio 


  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • SPAC BowX Agrees to $9 Billion Merger With WeWork 

  • Truebill Agrees to Sell to Rocket Companies for $1.275 Billion 

  • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 

  • Clarabridge Agrees to Sell to Qualtrics for $1.125 Billion 

  • View all


  • Harvard Law School
    JD, magna cum laude
    Joshua Montgomery Sears, Jr. Prize; founder and editor-in-chief of the Harvard Business Law Review

  • California State University - Fresno
    MBA, with distinction

  • California State University - Fresno
    BS, Finance
    summa cum laude

Admissions & Credentials

New York